Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma

NCT01663012 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Anaplastic Astrocytomas
Anaplastic Oligodendrogliomas
Glioblastomas (GBM)

Interventions

DRUG: Etirinotecan pegol

Sponsor

Lawrence Recht

Collaborators

[object Object]